
Ardena Moves to Expanded Headquarters in Belgium
Ardena has moved into its expanded headquarters, located in Gent, Belgium, as a result of continued growth.
Ardena, a contract development and manufacturing organization (CDMO), has moved to expanded headquarters in Gent, Belgium, as a result of sustained growth, it has revealed in a Nov. 8, 2018
Now operating across six sites, located in Belgium, the Netherlands, Sweden, and Latvia, the company has increased its employees from 40 to 250 and seen an increase in organic growth of more than 20% per year, which it states is a result of its merger and acquisition strategy.
"After several acquisitions and an ongoing growth period, we are firmly on track to reach our €35 million (approximately $40 million) sales target for 2018 as part of our wider strategy to become a leading integrated drug development company," said Harry Christiaens, CEO at Ardena in a
Inauguration of the new HQ took place on Oct. 25, 2018.
Source:
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





